Yang Liu
103Patents
5h-index
338Co-inventors
77Inventor score
Filing activity: Sep 20, 2001 → Mar 5, 2025
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8461134B2 | Boron-containing small molecules | Human Necessities | 21 | Active |
| US11566007B2 | Ras inhibitors | Human Necessities | 7 | Active |
| US11690915B2 | Ras inhibitors | Chemistry; Metallurgy | 7 | Active |
| US6875904B2 | Animal model for identifying agents that inhibit or enhance CTLA4 signaling | Chemistry; Metallurgy | 5 | Expired |
| US9777073B2 | Construction and application of bispecific antibody EpCAM×CD3 | Chemistry; Metallurgy | 5 | Active |
| US7504554B2 | Animal model for identifying agents that inhibit or enhance CTLA4 signaling | Chemistry; Metallurgy | 5 | Active |
| US8642029B2 | Transiently buffered Lactobacillus preparations and use thereof | Human Necessities | 4 | Active |
| US11952352B2 | Ras inhibitors | Human Necessities | 4 | Active |
| US10618960B2 | Chimeric and humanized anti-human CTLA4 monoclonal antibodies and uses thereof | Chemistry; Metallurgy | 4 | Active |
| US11168102B1 | Bicyclic heteroaryl compounds and uses thereof | Chemistry; Metallurgy | 4 | Active |
| US7161058B2 | Animal model for identifying agents that inhibit or enhance CTLA4 signaling | Chemistry; Metallurgy | 3 | Expired |
| US9744270B2 | Nanocrystalline cellulose hydrogels for inhibition of bacterial adhesion | Chemistry; Metallurgy | 3 | Active |
| US7744894B2 | Method of treating multiple sclerosis and related t-cell initiated tissue destruction by administering HSA/CD24 | Chemistry; Metallurgy | 3 | Active |
| US8163281B2 | Treatment of drug-related side effect and tissue damage by targeting the CD24-HMGB1-Siglec10 axis | Chemistry; Metallurgy | 3 | Active |
| US8808697B2 | Methods of use of soluble CD24 for therapy of rheumatoid arthritis | Chemistry; Metallurgy | 3 | Active |
| US12202845B2 | Ras inhibitors | Chemistry; Metallurgy | 2 | Active |
| US9751965B2 | Methods for preparation of propylene polymers | Chemistry; Metallurgy | 2 | Active |
| US12280113B2 | Ras inhibitors | Chemistry; Metallurgy | 2 | Active |
| US10556964B2 | Bispecific antibody-mediated cancer therapy with cytokine-induced killer cell | Chemistry; Metallurgy | 2 | Active |
| US10369197B2 | Use of CD24 for lowering low-density lipoprotein cholesterol levels | Physics | 1 | Active |
| US10537555B2 | Complex of angiotensin receptor antagonist and neutral endopeptidase inhibitor | Chemistry; Metallurgy | 1 | Active |
| US10961261B2 | Oxaborole analogs and uses thereof | Emerging Cross-Sectional Technologies | 1 | Active |
| US11401295B2 | Cyclic dinucleotide compound and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US8158596B2 | Materials and methods for FOXP3 tumor suppression | Physics | 1 | Active |
| US10562921B2 | Oxaborole esters and uses thereof | Emerging Cross-Sectional Technologies | 1 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.